TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
DFTX

Definium Therapeutics, Inc.

Healthcare · Biotechnology · —

36.20$ -1.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Definium Therapeutics, Inc. (DFTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 0.0 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement DFTX
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – 0.0 0.0 0.0 0.0 0.0
– – 0.0 0.0 0.0 – – – 3.2 0.5 –
– – 0.0 0.0 0.0 – – – -3.2 -0.5 –
– – – – – 19 35 36 49 65 118
– – – – – 14 59 30 42 39 49
0.1 0.1 1.2 0.9 0.5 33 94 66 91 103 166
-0.1 -0.1 -1.2 -0.9 -0.5 -33 -94 -66 -94 -104 -166
– – – – – 0.2 0.4 1.5 0.9 2.3 5.5
-0.1 -0.2 -1.2 -0.9 -1.1 -34 -94 -57 -96 -109 -184
0.0 – 0.0 0.0 0.0 – -1.2 – – – –
-0.1 -0.2 -1.2 -0.9 -1.1 -34 -93 -57 -96 -109 -184
-0.1 -0.1 -1.5 -0.9 -1.1 -34 -91 -52 -93 -106 -178

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?